Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MS
- 1 June 2012
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 58 (6) , 999-1009
Abstract
BACKGROUND: Abdominal adiposity and obesity influence the association of polycystic ovary syndrome (PCOS) with insulin resistance and diabetes. We aimed to characterize the intermediate metabolism phenotypes associated with PCOS and obesity. METHODS: We applied a nontargeted GC-MS metabolomic approach to plasma samples from 36 patients with PCOS and 39 control women without androgen excess, matched for age, body mass index, and frequency of obesity. RESULTS: Patients with PCOS were hyperinsulinemic and insulin resistant compared with the controls. The increase in plasma long-chain fatty acids, such as linoleic and oleic acid, and glycerol in the obese patients with PCOS suggests increased lipolysis, possibly secondary to impaired insulin action at adipose tissue. Conversely, nonobese patients with PCOS showed a metabolic profile consisting of suppression of lipolysis and increased glucose utilization (increased lactic acid concentrations) in peripheral tissues, and PCOS patients as a whole showed decreased 2-ketoisocaproic and alanine concentrations, suggesting utilization of branched-chain amino acids for protein synthesis and not for gluconeogenesis. These metabolic processes required effective insulin signaling; therefore, insulin resistance was not universal in all tissues of these women, and different mechanisms possibly contributed to their hyperinsulinemia. PCOS was also associated with decreased α-tocopherol and cholesterol concentrations irrespective of obesity. CONCLUSIONS: Substantial metabolic heterogeneity, strongly influenced by obesity, underlies PCOS. The possibility that hyperinsulinemia may occur in the absence of universal insulin resistance in nonobese women with PCOS should be considered when designing diagnostic and therapeutic strategies for the management of this prevalent disorder.Keywords
Funding Information
- Instituto de Investigación Carlos III (FIS PI080944, PI110357)
This publication has 39 references indexed in Scilit:
- The determinants of insulin sensitivity, β-cell function, and glucose tolerance are different in patients with polycystic ovary syndrome than in women who do not have hyperandrogenismFertility and Sterility, 2010
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) SocietyThe Journal of Clinical Endocrinology & Metabolism, 2010
- The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force reportFertility and Sterility, 2009
- Proteomics and genomics: A hypothesis‐free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndromeProteomics – Clinical Applications, 2008
- Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometryHuman Reproduction, 2008
- POSITION STATEMENT: Glucose Intolerance in Polycystic Ovary Syndrome—A Position Statement of the Androgen Excess SocietyThe Journal of Clinical Endocrinology & Metabolism, 2007
- Abdominal adiposity and the polycystic ovary syndromeTrends in Endocrinology & Metabolism, 2007
- Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2007
- A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from SpainThe Journal of Clinical Endocrinology & Metabolism, 2000
- Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.Diabetes Care, 1999